As of Jul 02
| -0.29 / -1.63%|
The 4 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 31.00, with a high estimate of 33.00 and a low estimate of 29.00. The median estimate represents a +76.94% increase from the last price of 17.52.
The current consensus among 4 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.